Gov. Gavin Newsom’s status as bestselling author is officially in doubt. Revelations his PAC, Campaign for Democracy, spent $1.6 million buying up copies of his book, has led to the New York Times ...
Based on a popular anime series, the film, subtitled “Tears of the Azure Sea,” is a satisfactory stand-alone fantasy ...
If you are hooked on the hit television show “The Pitt” get ready for a new episode on the horizon. Season 2 of the HBO show is nearing its end but the award-winning series has a new episode coming ...
Forbes contributors publish independent expert analyses and insights. Monica is an entertainment reporter covering TV, film, and music. Set 70 years after House of the Dragon and a century before the ...
They’re stealing from the rich to give to … themselves. A lefty New Yorker writer who lives in a $2.5 million Brooklyn brownstone has elicited fury from real hardworking New Yorkers after she claimed ...
Jeff Bezos' space company just notched a big reusability milestone — but also suffered a sizable setback. Blue Origin's huge New Glenn rocket launched into space for the third time ever Sunday morning ...
The killing of Ayatollah Ali Khamenei ushered in a new form of collective leadership in the country, with more power for the Revolutionary Guards. Iranians gathered last month in Tehran with flags and ...
Our Time for NYC was founded as a nonprofit political group after Zohran Mamdani’s election as mayor by members of the Democratic Socialists of America hoping to maintain the organizing energy. But ...
A oassport processing employee uses a stack of blank passports to print a new one at the Miami Passport Agency in Miami, Florida, June 22, 2007. Editorial Fellow The State Department on Tuesday ...
Blue Origin's New Glenn rocket is scheduled for its third launch from Florida on Sunday, April 19, 2026. The rocket is central to Jeff Bezos' goal of competing with SpaceX in the commercial space ...
Story by Koji Uchida The political stakes in the "Slime" world are hitting a boiling point! Currently streaming on ...
Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...